- Home
- ATYR vs DSY Comparison
ATYR vs DSY Comparison
Compare ATYR & DSY Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ATYR
- DSY
- Stock Information
- Founded
- ATYR 2005
- DSY 2020
- Country
- ATYR United States
- DSY China
- Employees
- ATYR N/A
- DSY N/A
- Industry
- ATYR Biotechnology: Biological Products (No Diagnostic Substances)
- DSY
- Sector
- ATYR Health Care
- DSY
- Exchange
- ATYR Nasdaq
- DSY Nasdaq
- Market Cap
- ATYR 77.1M
- DSY 85.8M
- IPO Year
- ATYR 2015
- DSY N/A
- Fundamental
- Price
- ATYR $0.71
- DSY $0.48
- Analyst Decision
- ATYR Buy
- DSY
- Analyst Count
- ATYR 6
- DSY 0
- Target Price
- ATYR $8.75
- DSY N/A
- AVG Volume (30 Days)
- ATYR 3.8M
- DSY 215.5K
- Earning Date
- ATYR 11-06-2025
- DSY 01-01-0001
- Dividend Yield
- ATYR N/A
- DSY N/A
- EPS Growth
- ATYR N/A
- DSY 120.37
- EPS
- ATYR N/A
- DSY 0.01
- Revenue
- ATYR $190,000.00
- DSY $7,323,356.00
- Revenue This Year
- ATYR $420.85
- DSY N/A
- Revenue Next Year
- ATYR $1,513.40
- DSY N/A
- P/E Ratio
- ATYR N/A
- DSY $40.58
- Revenue Growth
- ATYR N/A
- DSY 16.37
- 52 Week Low
- ATYR $0.68
- DSY $0.47
- 52 Week High
- ATYR $7.29
- DSY $7.33
- Technical
- Relative Strength Index (RSI)
- ATYR 29.54
- DSY 22.36
- Support Level
- ATYR $0.68
- DSY $0.53
- Resistance Level
- ATYR $0.77
- DSY $0.61
- Average True Range (ATR)
- ATYR 0.06
- DSY 0.04
- MACD
- ATYR 0.03
- DSY 0.00
- Stochastic Oscillator
- ATYR 11.19
- DSY 1.20
About ATYR aTyr Pharma Inc. Common Stock
aTyr Pharma Inc is a biotherapeutics company engaged in the discovery and development of first-in-class medicines from its proprietary tRNA synthetase platform. The company has concentrated its research and development efforts on a newly discovered area of biology, the extracellular functionality and signaling pathways of tRNA synthetases. Its primary focus is efzofitimod, a clinical-stage product candidate which targets NRP2 to resolve chronic inflammation that can cause to fibrosis. Efzofitimod has a novel mechanism of action for potentially treating lung inflammation and fibrosis.
About DSY Big Tree Cloud Holdings Limited Ordinary Shares
Big Tree Cloud Holdings Ltd is a consumer-oriented, mission-driven, and technology-empowered company engaged in the development, production, and sales of personal care products and other consumer goods. In particular, it is focused on the development and production of feminine pads and other feminine hygiene products. Through its platform, the company focuses on high-quality product development, deep customer engagement, and efficient sales and marketing.